179 related articles for article (PubMed ID: 30897722)
1. Defining Processing Times for Accelerator Produced
Fitzsimmons J; Griswold J; Medvedev D; Cutler CS; Mausner L
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897722
[TBL] [Abstract][Full Text] [Related]
2. Chromatographic separation of the theranostic radionuclide
Mastren T; Radchenko V; Engle JW; Weidner JW; Owens A; Wyant LE; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
Anal Chim Acta; 2018 Jan; 998():75-82. PubMed ID: 29153089
[TBL] [Abstract][Full Text] [Related]
3. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes.
Radchenko V; Engle JW; Wilson JJ; Maassen JR; Nortier FM; Taylor WA; Birnbaum ER; Hudston LA; John KD; Fassbender ME
J Chromatogr A; 2015 Feb; 1380():55-63. PubMed ID: 25596759
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other Metals.
Fitzsimmons J; Foley B; Torre B; Wilken M; Cutler CS; Mausner L; Medvedev D
Molecules; 2019 May; 24(10):. PubMed ID: 31109077
[TBL] [Abstract][Full Text] [Related]
5. Large scale accelerator production of
Griswold JR; Medvedev DG; Engle JW; Copping R; Fitzsimmons JM; Radchenko V; Cooley JC; Fassbender ME; Denton DL; Murphy KE; Owens AC; Birnbaum ER; John KD; Nortier FM; Stracener DW; Heilbronn LH; Mausner LF; Mirzadeh S
Appl Radiat Isot; 2016 Dec; 118():366-374. PubMed ID: 27776333
[TBL] [Abstract][Full Text] [Related]
6. 225Ac and 223Ra production via 800 MeV proton irradiation of natural thorium targets.
Weidner JW; Mashnik SG; John KD; Ballard B; Birnbaum ER; Bitteker LJ; Couture A; Fassbender ME; Goff GS; Gritzo R; Hemez FM; Runde W; Ullmann JL; Wolfsberg LE; Nortier FM
Appl Radiat Isot; 2012 Nov; 70(11):2590-5. PubMed ID: 22944532
[TBL] [Abstract][Full Text] [Related]
7. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT).
Baimukhanova A; Engudar G; Marinov G; Kurakina E; Dadakhanov J; Karaivanov D; Yang H; Ramogida CF; Schaffer P; Magomedbekov EP; Filosofov D; Radchenko V
Nucl Med Biol; 2022; 112-113():35-43. PubMed ID: 35797877
[TBL] [Abstract][Full Text] [Related]
8. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.
Perron R; Gendron D; Causey PW
Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503
[TBL] [Abstract][Full Text] [Related]
9. Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV.
Weidner JW; Mashnik SG; John KD; Hemez F; Ballard B; Bach H; Birnbaum ER; Bitteker LJ; Couture A; Dry D; Fassbender ME; Gulley MS; Jackman KR; Ullmann JL; Wolfsberg LE; Nortier FM
Appl Radiat Isot; 2012 Nov; 70(11):2602-7. PubMed ID: 22940414
[TBL] [Abstract][Full Text] [Related]
10. Production of
Friend MT; Mastren T; Parker TG; Vermeulen CE; Brugh M; Birnbaum ER; Nortier FM; Fassbender ME
Appl Radiat Isot; 2020 Feb; 156():108973. PubMed ID: 31727509
[TBL] [Abstract][Full Text] [Related]
11. Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV.
Duchemin C; Guertin A; Haddad F; Michel N; Métivier V
Phys Med Biol; 2015 Feb; 60(3):931-46. PubMed ID: 25574934
[TBL] [Abstract][Full Text] [Related]
12. Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRh.
Mastren T; Radchenko V; Hopkins PD; Engle JW; Weidner JW; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
PLoS One; 2017; 12(12):e0190308. PubMed ID: 29272318
[TBL] [Abstract][Full Text] [Related]
13.
Robertson AKH; McNeil BL; Yang H; Gendron D; Perron R; Radchenko V; Zeisler S; Causey P; Schaffer P
Inorg Chem; 2020 Sep; 59(17):12156-12165. PubMed ID: 32677829
[TBL] [Abstract][Full Text] [Related]
14. The application of poorly crystalline silicotitanate in production of
Fitzsimmons J; Abraham A; Catalano D; Younes A; Cutler CS; Medvedev D
Sci Rep; 2019 Aug; 9(1):11808. PubMed ID: 31413268
[TBL] [Abstract][Full Text] [Related]
15. Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.
McAlister DR; Horwitz EP
Appl Radiat Isot; 2018 Oct; 140():18-23. PubMed ID: 29936271
[TBL] [Abstract][Full Text] [Related]
16. Cyclotron production of Ac-225 for targeted alpha therapy.
Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Data Evaluation for Mass Chain A=217:Odd-Proton Nuclei.
Nafee SS; Shaheen SA; Al-Ramady AM
PLoS One; 2016; 11(1):e0146182. PubMed ID: 26761207
[TBL] [Abstract][Full Text] [Related]
18. Relativistic small-core pseudopotentials for actinium, thorium, and protactinium.
Weigand A; Cao X; Hangele T; Dolg M
J Phys Chem A; 2014 Apr; 118(13):2519-30. PubMed ID: 24628327
[TBL] [Abstract][Full Text] [Related]
19. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
[TBL] [Abstract][Full Text] [Related]
20. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
